We are live on ! Find out more
CIP

Convergence Investment Partners Portfolio holdings

AUM $1.06B
1-Year Est. Return 87.75%
This Fund
S&P 500
This Quarter Est. Return
-4.2%
1 Year Est. Return
+87.75%
3 Year Est. Return
+284.26%
5 Year Est. Return
+379.02%
10 Year Est. Return
+1,390.46%
AUM
$153M
AUM Growth
-$12.1M
Cap. Flow
-$1.82M
Cap. Flow %
-1.19%
Top 10 Hldgs %
21.35%
Holding
258
New
56
Increased
66
Reduced
77
Closed
59

Top Buys

Rank Stock Value
1
LAZ icon
Lazard
LAZ
+$1.25M
2
GILD icon
Gilead Sciences
GILD
+$1.17M
3
EIX icon
Edison International
EIX
+$1.14M
4
AMGN icon
Amgen
AMGN
+$1.12M
5
CSCO icon
Cisco
CSCO
+$963K

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$2.41M
2
HPQ icon
HP
HPQ
+$1.91M
3
MPC icon
Marathon Petroleum
MPC
+$1.47M
4
DUK icon
Duke Energy
DUK
+$1.36M
5
JEF icon
Jefferies Financial Group
JEF
+$1.12M

Sector Composition

Rank Sector Weight
1 Technology 19.11%
2 Healthcare 16.75%
3 Financials 16.1%
4 Consumer Discretionary 8.77%
5 Communication Services 8.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMY icon
76
Bristol-Myers Squibb
BMY
$132B
$705K 0.46%
9,920
-325
-3% -$23.6K
CC icon
77
Chemours
CC
$2.37B
$676K 0.44%
27,410
+4,264
+18% +$141K
MA icon
78
Mastercard
MA
$493B
$646K 0.42%
2,273
-72
-3% -$23.9K
BAC icon
79
Bank of America
BAC
$442B
$642K 0.42%
21,270
-2,624
-11% -$87.7K
PG icon
80
Procter & Gamble
PG
$339B
$635K 0.41%
5,031
-1,634
-25% -$232K
CI icon
81
Cigna
CI
$74.6B
$629K 0.41%
2,266
+21
+0.9% +$5.91K
MCK icon
82
McKesson
MCK
$101B
$580K 0.38%
1,706
-820
-32% -$285K
DVN icon
83
Devon Energy
DVN
$47.3B
$579K 0.38%
+9,636
New +$599K
WFC icon
84
Wells Fargo
WFC
$264B
$545K 0.36%
13,558
-4,138
-23% -$178K
CDNS icon
85
Cadence Design Systems
CDNS
$93.4B
$520K 0.34%
3,183
+311
+11% +$53.5K
PEP icon
86
PepsiCo
PEP
$190B
$513K 0.34%
3,141
-146
-4% -$25.2K
VRTX icon
87
Vertex Pharmaceuticals
VRTX
$126B
$512K 0.33%
1,768
+451
+34% +$130K
COR icon
88
Cencora
COR
$61.2B
$501K 0.33%
3,704
-154
-4% -$22.1K
JBL icon
89
Jabil
JBL
$35.8B
$501K 0.33%
8,680
-502
-5% -$29.2K
COST icon
90
Costco
COST
$420B
$493K 0.32%
1,043
-169
-14% -$87.9K
LLY icon
91
Eli Lilly
LLY
$1.06T
$492K 0.32%
1,522
-104
-6% -$33K
SNPS icon
92
Synopsys
SNPS
$79.7B
$452K 0.3%
+1,479
New +$501K
UI icon
93
Ubiquiti
UI
$34.3B
$449K 0.29%
+1,530
New +$451K
MPC icon
94
Marathon Petroleum
MPC
$83.7B
$443K 0.29%
4,459
-15,679
-78% -$1.47M
MCHP icon
95
Microchip Technology
MCHP
$46B
$441K 0.29%
7,222
+3,462
+92% +$227K
NVDA icon
96
NVIDIA
NVDA
$5.42T
$438K 0.29%
36,070
-2,570
-7% -$40.6K
CNC icon
97
Centene
CNC
$32.5B
$425K 0.28%
5,467
-22
-0.4% -$1.97K
EA
98
DELISTED
Electronic Arts
EA
$419K 0.27%
+3,617
New +$458K
ELV icon
99
Elevance Health
ELV
$85.5B
$373K 0.24%
820
-151
-16% -$72.3K
LOW icon
100
Lowe's Companies
LOW
$125B
$371K 0.24%
1,978
-82
-4% -$16K
2 3
4
5 6

Similar funds

MWA
Monograph Wealth Advisors Manhattan Beach, California $1.05B AUM 23.2% 1-Year Est. Return
SFP
Shepherd Financial Partners Winchester, Massachusetts $1.05B AUM 22.07% 1-Year Est. Return
ECM
Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return
NRG
Nemes Rush Group Novi, Michigan $1.05B AUM 30.08% 1-Year Est. Return
LAM
L2 Asset Management Wayland, Massachusetts $1.05B AUM 29.07% 1-Year Est. Return
BGIM
Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return
CIA
Compass Ion Advisors Conshohocken, Pennsylvania $1.05B AUM 16.28% 1-Year Est. Return
AA
Apriem Advisors Irvine, California $1.05B AUM 22.09% 1-Year Est. Return

Convergence Investment Partners's Q3 2022 Portfolio in Review

As of Q3 2022, Convergence Investment Partners held 258 positions worth $153M, down 7.3% from $165M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Convergence Investment Partners's Q3 2022 filing shows 56 new, 66 increased, 77 reduced and 59 closed positions. Its largest new stake was Lazard: 34,896 shares worth $1.11M. The largest sale was Pfizer, an estimated $2.41M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.

  • Convergence Investment Partners's largest Q3 2022 buy was Lazard: 34,896 shares worth $1.11M.
  • Convergence Investment Partners added most to Gilead Sciences in Q3 2022, an estimated $1.17M increase.
  • Convergence Investment Partners's biggest Q3 2022 reduction was Pfizer, cutting an estimated $2.41M.
  • Convergence Investment Partners fully exited HP in Q3 2022, selling an estimated $1.91M.
  • Convergence Investment Partners's ten largest holdings make up 21% of its $153M portfolio in Q3 2022.
  • Convergence Investment Partners opened 56 new positions and closed 59 in Q3 2022.
  • Convergence Investment Partners's portfolio value fell 7.3% quarter-over-quarter to $153M.

Based on Convergence Investment Partners's 13F filing for Q3 2022, filed 8 Nov 2022.